Impact of psychotropic drugs on suicide and suicidal behaviors
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Objective: To examine the impact of psychotropic drugs on suicide and suicidal behaviors in bipolar disorders. Methods: A Medline search of articles published from January 1960 to January 2013 was performed using relevant keywords to identify studies examining the relationship of psychotropic drugs to suicidal behaviors. The publications were further reviewed for relevant references and information. Additionally, the US Food and Drug Administration Center for Drug Evaluation Research website was searched. Results: The available studies used differing methodologies, making interpretation of the findings difficult. Studies suggest that antidepressants may increase suicidal risk in bipolar disorder, this possibly being related to the induction of broadly defined mixed states. There is no evidence that antiepileptic drugs as a class increase suicidal risk in patients with bipolar disorder. Only lithium provides convincing data that it reduces the risk of suicide over the long term. There is little known regarding the effects of antipsychotics, as well as anti‐anxiety and hypnotic drugs, on suicidal behavior. Conclusions: The available evidence for the impact of psychotropics on suicidal risk in patients with bipolar disorder is largely methodologically flawed and, except for a few instances, clinically not useful at this point. Adequately powered, prospective randomized controlled studies are needed to assess the impact of each class of psychotropic and each psychotropic as well as common combination therapies. Until such studies have been carried out, clinicians are urged to exercise caution in using these drugs and rely on the traditional means of carefully assessing and monitoring patients with bipolar disorder who are at high risk for suicide.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Suicide as an outcome for mental disorders: A meta-analysis
Harris, E. C., & Barraclough, B. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.170.3.205 · Cited by 2,589
The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Maser, J., Solomon, D. A., Leon, A. C., Rice, J. A., & Keller, M. B. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.530 · Cited by 2,106
Meltzer, H. Y. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.1.82 · Cited by 1,393 · cited 1×
“(112) conducted a multicenter randomized control trial comparing olanzapine to clozapine in a group of schizophrenic and schizoaffective patients at risk for suicide.”
BackgroundTiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Niskanen, L., Tanskanen, A., & Haukka, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60742-x · Cited by 1,354
Suicidality in Pediatric Patients Treated With Antidepressant Drugs
Hammad, T. A., Laughren, T., & Racoosin, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.332 · Cited by 1,054
Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
Sachs, G. S., Nierenberg, A. A., Calabrese, J. R., Marangell, L. B., Wisniewski, S. R., Gyulai, L., Friedman, E. S., Bowden, C. L., Fossey, M. D., Ostacher, M. J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064135 · Cited by 937 · cited 1×
“The addition of antidepressants may not have a significant impact in the treatment of bipolar depression (43).”
BackgroundTohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1079 · Cited by 908
Calabrese, J. R., Keck, P. E., Macfadden, W., Minkwitz, M., Ketter, T. A., Weisler, R. H., Cutler, A. J., McCoy, R., Wilson, E., Mullen, J., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.7.1351 · Cited by 883 · cited 1×
“In a short-term randomized controlled trial of bipolar depression, patients on quetiapine had greater reductions in suicidal ideation ratings compared to patients on placebo (117).”
Decreased risk of suicides and attempts during long‐term lithium treatment: a meta‐analytic review
Baldessarini, R. J., Tondo, L., Davis, P., Pompili, M., Goodwin, F. K., & Hennen, J. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00344.x · Cited by 753
Bowden, C. L. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.5.481 · Cited by 678 · cited 2×
“Relapse rates are still high for lithium and divalproex (48).”
BackgroundThe Relationship Between Antidepressant Medication Use and Rate of Suicide
Gibbons, R. D., Hur, K., Bhaumik, D. K., & Mann, J. J. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.2.165 · Cited by 393
Long-term symptomatic status of bipolar I vs. bipolar II disorders
Judd, L. L., Schettler, P. J., Akiskal, H. S., Maser, J., Coryell, W., Solomon, D., Endicott, J., & Keller, M. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003341 · Cited by 389 · cited 1×
“Thus there is a clinical dilemma (45, 49– 51) that is also a major public health concern, since the estimated 50 million patients with bipolar disorder in the world spend the majority of their ill time in depression rather than mania and are thus ‘vulnerable’ to antidepressant treatment (52, 53).”
BackgroundMood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline
Post, R. M., Altshuler, L. L., Leverich, G. S., Frye, M. A., Nolen, W. A., Kupka, R. W., Suppes, T., McElroy, S., Keck, P. E., Denicoff, K. D., et al. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.bp.105.013045 · Cited by 350 · cited 1×
“The impression that bupropion may cause less switching or fewer mixed states when used in bipolar depression may be a potential advantage in this regard (66, 71).”
BackgroundPsychiatric Diagnoses and Risk of Suicide in Veterans
Ilgen, M. A., Bohnert, A. S. B., Ignacio, R. V., McCarthy, J. F., Valenstein, M. M., Kim, H. M., & Blow, F. C. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.129 · Cited by 311
Tiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Tanskanen, A., & Haukka, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.12.1358 · Cited by 277 · cited 1×
“(69) reported that, among various antidepressants, fluoxetine was associated with the lowest risk of suicide compared to placebo (RR = 0.”
BackgroundSleep Disturbance in Bipolar Disorder: Therapeutic Implications
Plante, D. T., & Winkelman, J. W. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08010077 · Cited by 268 · cited 1×
“One difficulty in assessing the contribution of these drugs to increased suicidality is that insomnia can be an independent risk factor for suicidality in bipolar disorder (131).”
BackgroundYatham, L. N., Kennedy, S. H., O'Donovan, C., Parikh, S. V., MacQueen, G., McIntyre, R. S., Sharma, V., Beaulieu, S., & for CANMAT guidelines group (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00432.x · Cited by 264
Suicide-Related Events in Patients Treated with Antiepileptic Drugs
Arana, A., Wentworth, C. E., Ayuso-Mateos, J. L., & Arellano, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909801 · Cited by 205
Oquendo, M. A., Galfalvy, H. C., Currier, D., Grunebaum, M. F., Sher, L., Sullivan, G. M., Burke, A. K., Harkavy-Friedman, J., Sublette, M. E., Parsey, R. V., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11010163 · Cited by 165
Relationship Between Antiepileptic Drugs and Suicide Attempts in Patients With Bipolar Disorder
Gibbons, R. D., Hur, K., Brown, C. H., & Mann, J. J. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.159 · Cited by 156 · cited 1×
“(101), in a pharmaco-epidemiological study of bipolar disorder patients in a large medical claims database, compared the rates of suicide attempts associated with AEDs versus lithium monotherapy.”
BackgroundLauterbach, E., Felber, W., Müller‐Oerlinghausen, B., Ahrens, B., Bronisch, T., Meyer, T., Kilb, B., Lewitzka, U., Hawellek, B., Quante, A., et al. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01266.x · Cited by 154 · cited 1×
“(84) indicated that adjunctive lithium treatment, although not associated with a reduction in suicide attempts, may be effective in reducing completed suicides in adult affectively ill patients.”
BackgroundStress, Genes and the Biology of Suicidal Behavior
Currier, D., & Mann, J. J. (2008) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2008.01.005 · Cited by 142
Meyer, R. E., Salzman, C., Youngstrom, E. A., Clayton, P. J., Goodwin, F. K., Mann, J. J., Alphs, L. D., Broich, K., Goodman, W. K., Greden, J. F., et al. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10cs06070blu · Cited by 129 · cited 1×
“A recent expert consensus statement (25) on the issue agreed with the FDA’s endorsement of the terminology of the Columbia Classification Algorithm of Suicide Assessment (C-CASA) with the hope that industry and clinical researchers will use C-CASA compatible instruments in monitoring treatment-emergent suicidal behavi…”
BackgroundSuicide in a large population of former psychiatric inpatients
Sani, G., Tondo, L., Koukopoulos, A., Reginaldi, D., Kotzalidis, G. D., Koukopoulos, A. E., Manfredi, G., Mazzarini, L., Pacchiarotti, I., Simonetti, A., et al. (2011) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2011.02205.x · Cited by 119 · cited 1×
“(90) found that longer term treatments with lithium and anticonvulsants were associated with decreased risk of completed suicide compared to shorter term treatments which they assessed as positively predicting completed suicide.”
BackgroundSachs, G. S., Ice, K. S., Chappell, P. B., Schwartz, J. H., Gurtovaya, O., Vanderburg, D. G., & Kasuba, B. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05934 · Cited by 101
Amaddeo, F., Bisoffi, G., Bonizzato, P., Micciolo, R., & Tansella, M. (1995) · British Journal of Psychiatry · doi:10.1192/bjp.166.6.783 · Cited by 77
Fatal intoxications in a Swedish forensic autopsy material during 1992–2002
Jönsson, A., Holmgren, P., & Ahlner, J. (2004) · Forensic Science International · doi:10.1016/j.forsciint.2004.02.010 · Cited by 64
Aripiprazole monotherapy in the treatment of bipolar disorder: A meta-analysis
Fountoulakis, K. N., Vieta, E., & Schmidt, F. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.10.018 · Cited by 52 · cited 1×
“(123) found the suicide rates to be negligible in mania groups treated with aripiprazole, but results in bipolar depression were not reported in the studies reviewed.”
ResultAhearn, E. P., Chen, P., Hertzberg, M., Cornette, M., Suvalsky, L., Cooley-Olson, D., Swanlund, J., Eickhoff, J., Becker, T., & Krahn, D. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.07.015 · Cited by 45
Cited by
Schaffer, A., Isometsä, E. T., Tondo, L., H Moreno, D., Turecki, G., Reis, C., Cassidy, F., Sinyor, M., Azorin, J., Kessing, L. V., et al. (2015) · Bipolar Disorders · doi:10.1111/bdi.12271 · Cited by 335
Lithium and suicide in mood disorders: Updated meta‐review of the scientific literature
Smith, K. A., & Cipriani, A. (2017) · Bipolar Disorders · doi:10.1111/bdi.12543 · Cited by 247
Schaffer, A., Isometsä, E. T., Tondo, L., Moreno, D. H., Sinyor, M., Kessing, L. V., Turecki, G., Weizman, A., Azorin, J.-M., Ha, K., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415594427 · Cited by 175
“This was supplemented by manual examination of reference lists of articles, recently published reviews on suicide or suicide attempts in BD (Baethge and Cassidy, 2013; Chesin and Stanley, 2013; Hauser et al., 2013; Malhi et al., 2013; Pompili et al., 2013; Saunders and Hawton, 2013; Yerevanian and Choi, 2013), and dat…”
InfluentialGrunebaum, M. F., Ellis, S. P., Keilp, J. G., Moitra, V. K., Cooper, T. B., Marver, J. E., Burke, A. K., Milak, M. S., Sublette, M. E., Oquendo, M. A., et al. (2017) · Bipolar Disorders · doi:10.1111/bdi.12487 · Cited by 174
Schaffer, A., Isometsä, E. T., Azorin, J.-M., Cassidy, F., Goldstein, T., Rihmer, Z., Sinyor, M., Tondo, L., Moreno, D. H., Turecki, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415594428 · Cited by 120
“A number of excellent reviews of this area have been published over the years (Baethge and Cassidy, 2013; Gonda et al., 2012; Hawton et al., 2005b; Malhi et al., 2013; Mathews et al., 2013; Pompili et al., 2013; Yerevanian and Choi, 2013), and our ISBD task force also separately conducted a series of meta-analyses on…”
Method
Metadata
- Authors
- Yerevanian, B. I., & Choi, Y. M.
- Venue
- Bipolar Disorders
- Publisher
- Wiley
- Published
- 2013-07-19
- Volume
- 15
- Issue
- 5
- Pages
- 594-621
- ISSN
- 1398-5647 (ISSN-L)
- 1399-5618
- OpenAlex
- W2129777289
- Cited by
- 51
- References
- 29
- FWCI
- 5.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.